Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FSPE6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,581
Award facts
- Contract value 100% obligated
- $59,581.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59.6K delivery order to AmerisourceBergen Drug Corp for KESIMPTA 20 mg/0.4 ml pen (ofatumumab), a monoclonal antibody used to treat relapsing forms of multiple sclerosis. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed price structure with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1.0B pharmaceutical prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through open competition. The company's extensive portfolio with the Defense Logistics Agency encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for KESIMPTA supports the military healthcare supply chain and aligns with the company's established capability to fulfill diverse pharmaceutical requirements for the Defense Health Agency and other federal healthcare systems through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DB25FSPE6?
SPE2DB25FSPE6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FSPE6 worth?
The government has obligated $59,581 on SPE2DB25FSPE6.
Is contract SPE2DB25FSPE6 an order under another contract?
Yes. SPE2DB25FSPE6 is a delivery order under SPE2DB20D7061, an indefinite delivery contract.
Was contract SPE2DB25FSPE6 competed?
The extent of competition for SPE2DB25FSPE6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award